Glucotrack, Inc. Files 8‑K/A Confirming Completed Asset Acquisition

What Happened
Glucotrack, Inc. (GCTK) filed an amendment to a previously reported Form 8‑K on August 28, 2026, addressing Item 2.01 (Completion of Acquisition or Disposition of Assets) and Item 9.01 (Financial Statements and Exhibits). The amendment states it does not reflect events after the Original Report and does not update prior disclosures except as expressly provided in the amendment.

Key Details

• Filing date: August 28, 2026 (Form 8‑K/A).
• Items reported: Item 2.01 — Completion of Acquisition or Disposition of Assets; Item 9.01 — Financial Statements and Exhibits.
• Scope: Amendment supplies or references financial statements/exhibits related to the transaction and clarifies it does not amend or update the Original Report’s disclosures except as noted.
• No new events: The company explicitly states the amendment does not reflect any events occurring after the Original Report.

Why It Matters
A completed acquisition can affect Glucotrack’s assets, operations, and future financial results; the amendment’s attached financial statements/exhibits are where investors should look for transaction impact and accounting treatment. Because the filing does not change prior disclosures, investors should review both the Original 8‑K and this amendment to understand the full transaction details and any supporting financial information.